Boston Scientific · 2 months ago
Senior Embedded Software Manager
Boston Scientific is a leader in medical science, dedicated to solving critical health challenges. They are seeking a Senior Embedded Software Manager to lead a team of engineers in developing innovative firmware solutions for implantable medical devices, ensuring compliance with industry regulations.
Health CareMedicalMedical Device
Responsibilities
Managing the team to execute programs in line with short and long term strategic vision for technologies, indications, research, use models and intellectual property for BSC products and services
Align, represent, communicate and guide the team to execute Corporate, Divisional and Functional mission, vision, goals and values
Manage team to perform according to best practices within functional area of expertise, keeping a high standard of executional excellence
Plan, manage, hire and assign resources to projects
Drive technical projects of major magnitude and scope, by coordinating with the project managers/core team leaders
Function as reviewer for technical solutions, source code, architecture designs, etc
Qualification
Required
Bachelor's or Master's degree in an engineering field including (but not limited to) software engineering, computer science, electrical or electronic engineering
6+ years of experience in software development
3+ years of experience leading engineers, as manager or technical leader
Proven experience in a regulated industry
Preferred
Master's degree in Electrical or Electronic Engineering
10+ years of experience, including a significant portion of it managing embedded firmware teams
Proven experience in the Medical Device Industry. Familiarity with IEC62304 and IEC60601
Experience with C/C++ in a microcontroller environment
Excellent written and verbal communication skills
Experience working with multinational teams, external contractors and consultants
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2025-12-25
2025-12-12
Company data provided by crunchbase